Welcome to our interactive and engaging educational initiative on managing anemia in myelodysplastic syndromes (MDS). Anemia is a common issue in MDS, causing symptoms like fatigue, pallor, shortness of breath, and light-headedness. It can have a significant impact on patients' quality of life and lead to complications such as iron overload and red blood cell transfusion dependence. Moreover, anemia and transfusion dependence are associated with poor outcomes in MDS. In this program, you will learn the optimal time to initiate anemia treatment, how best to dose luspatercept and address adverse events, and familiarize yourself with emerging data in the treatment of anemia related to low-risk MDS to better help your patients.

CME/CE Accreditation Information